This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Healthy Subjects
and you are
between 18 and 50
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study will compare two different formulations of vabicaserin.

Provided treatments

  • Drug: vabicaserin
Tris trial is registered with FDA with number: NCT00928551. The sponsor of the trial is Wyeth is now a wholly owned subsidiary of Pfizer and it is looking for 15 volunteers for the current phase.
Official trial title:
A Randomized, Open-Label, Single-Dose, 3-Period Crossover, Comparative Study of a Modified Formulation of Vabicaserin (SCA-136) Versus the Reference Formulation in Healthy Subjects